KRW175,800.00
0.57% today
Korea, Nov 26, 07:09 am CET
ISIN
KR7068270008
Symbol
068270
Index
Sector
Industry

Celltrion Stock price

KRW175,600.00
-12,100.00 6.45% 1M
-4,000.00 2.23% 6M
-25,900.00 12.85% YTD
+13,231.14 8.15% 1Y
-24,445.96 12.22% 3Y
+18,491.73 11.77% 5Y
+146,307.70 499.47% 10Y
Korea, Closing price Tue, Nov 26 2024
-1,200.00 0.68%
ISIN
KR7068270008
Symbol
068270
Index
Sector
Industry

Key metrics

Market capitalization KRW36.45t
Enterprise Value KRW37.60t
P/E (TTM) P/E ratio 195.10
EV/FCF (TTM) EV/FCF 66.23
EV/Sales (TTM) EV/Sales 13.07
P/S ratio (TTM) P/S ratio 12.67
P/B ratio (TTM) P/B ratio 2.16
Dividend yield 0.28%
Last dividend (FY22) KRW500.00
Revenue growth (TTM) Revenue growth 24.81%
Revenue (TTM) Revenue KRW2.88t
EBIT (operating result TTM) EBIT KRW314.01b
Free Cash Flow (TTM) Free Cash Flow KRW567.77b
Cash position KRW1.18t
EPS (TTM) EPS KRW906.18
P/E forward 86.82
P/S forward 10.41
EV/Sales forward 10.74
Show more

Is Celltrion a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Celltrion Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Celltrion forecast:

16x Buy
80%
3x Hold
15%
1x Sell
5%

Analyst Opinions

20 Analysts have issued a Celltrion forecast:

Buy
80%
Hold
15%
Sell
5%

Financial data from Celltrion

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,876,253 2,876,253
25% 25%
100%
- Direct Costs 1,765,797 1,765,797
42% 42%
61%
1,110,456 1,110,456
4% 4%
39%
- Selling and Administrative Expenses 195,168 195,168
643% 643%
7%
- Research and Development Expense 188,971 188,971
26% 26%
7%
726,316 726,316
24% 24%
25%
- Depreciation and Amortization 412,307 412,307
91% 91%
14%
EBIT (Operating Income) EBIT 314,009 314,009
57% 57%
11%
Net Profit 187,097 187,097
69% 69%
7%

In millions KRW.

Don't miss a Thing! We will send you all news about Celltrion directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Celltrion, Inc. engages in the development, manufacture and distribution of pharmaceuticals. It operates through the Biopharmaceuticals, Chemical Drugs and Others businesses. Its products include remsima and biosimilars. The company was founded on February 27, 1991 and is headquartered in Incheon, South Korea.

Head office South Korea
CEO Wu-Sung Ki
Employees 2,529
Founded 1991
Website www.celltrion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today